Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.…
Bitcoin falls as Strategy faces MSCI index shake-up
Upexi (NASDAQ: UPXI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Internet Content & Information industry, part of the Communication Services sector, and reports about 10 employees.
The shares were at 0.4622 USD on 20 November 2026, down 86.0% over 52 weeks. Its 52-week range is 0.4205 USD to 3.650 USD: the price is 87.3% below the high and 9.9% above the low.
Its market capitalisation is 41.07M USD.
Upexi reports return on equity of 457.3% and revenue down 62.3% year over year.
Its debt exceeds its cash by 214.85M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 9 February 2027.